Variant report

Variant	esv3319120
Chromosome Location	chr19:23871416-23968511
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:740)
CpG islands
(count:1464)
Chromatin interactive
region (count:16)
LncRNA
region (count:8)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:740 , 50 per page) page: 1 2 3 4 5 6 7 ... 15

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr19:23946565-23946828	K562	blood:	n/a	n/a
2	ARID3A	chr19:23953533-23953728	K562	blood:	n/a	n/a
3	ARID3A	chr19:23941611-23941919	K562	blood:	n/a	n/a
4	ATF1	chr19:23958138-23958329	K562	blood:	n/a	n/a
5	ATF1	chr19:23941540-23941902	K562	blood:	n/a	n/a
6	BACH1	chr19:23922436-23922552	K562	blood:	n/a	n/a
7	BATF	chr19:23955472-23955714	GM12878	blood:	n/a	n/a
8	BATF	chr19:23955417-23955716	GM12878	blood:	n/a	n/a
9	BATF	chr19:23967036-23967332	GM12878	blood:	n/a	n/a
10	BATF	chr19:23967080-23967345	GM12878	blood:	n/a	n/a
11	BHLHE40	chr19:23911603-23911632	GM12878	blood:	n/a	n/a
12	BHLHE40	chr19:23968376-23968383	K562	blood:	n/a	n/a
13	BHLHE40	chr19:23945754-23945986	K562	blood:	n/a	n/a
14	BHLHE40	chr19:23941310-23941885	K562	blood:	n/a	n/a
15	BHLHE40	chr19:23943218-23943418	GM12878	blood:	n/a	n/a
16	CBX3	chr19:23945432-23946054	K562	blood:	n/a	n/a
17	CBX3	chr19:23941229-23941835	K562	blood:	n/a	n/a
18	CBX3	chr19:23889464-23889761	K562	blood:	n/a	n/a
19	CCNT2	chr19:23945563-23946451	K562	blood:	n/a	n/a
20	CEBPB	chr19:23959164-23959407	A549	lung:	n/a	n/a
21	CEBPB	chr19:23959198-23959416	IMR90	lung:	n/a	n/a
22	CEBPB	chr19:23959200-23959410	K562	blood:	n/a	n/a
23	CEBPB	chr19:23903520-23903860	A549	lung:	n/a	chr19:23903671-23903682
24	CEBPB	chr19:23957213-23957908	K562	blood:	n/a	n/a
25	CEBPB	chr19:23934776-23934927	A549	lung:	n/a	n/a
26	CEBPB	chr19:23965616-23965852	A549	lung:	n/a	chr19:23965729-23965740
27	CEBPB	chr19:23940391-23940983	K562	blood:	n/a	n/a
28	CEBPB	chr19:23959992-23961064	A549	lung:	n/a	n/a
29	CEBPB	chr19:23903539-23903805	H1-hESC	embryonic stem cell:	n/a	chr19:23903671-23903682
30	CEBPB	chr19:23946654-23946904	K562	blood:	n/a	n/a
31	CEBPB	chr19:23891590-23891809	A549	lung:	n/a	chr19:23891666-23891679 chr19:23891666-23891677 chr19:23891668-23891677 chr19:23891668-23891679
32	CEBPB	chr19:23964661-23965311	HepG2	liver:	n/a	n/a
33	CEBPB	chr19:23952624-23952715	HepG2	liver:	n/a	n/a
34	CEBPB	chr19:23891526-23891826	HepG2	liver:	n/a	chr19:23891666-23891679 chr19:23891666-23891677 chr19:23891668-23891677 chr19:23891668-23891679
35	CEBPB	chr19:23957266-23957876	IMR90	lung:	n/a	n/a
36	CEBPB	chr19:23945549-23946148	K562	blood:	n/a	n/a
37	CEBPB	chr19:23941547-23941789	K562	blood:	n/a	n/a
38	CEBPB	chr19:23903502-23903839	IMR90	lung:	n/a	chr19:23903671-23903682
39	CEBPB	chr19:23891562-23891820	IMR90	lung:	n/a	chr19:23891666-23891679 chr19:23891666-23891677 chr19:23891668-23891677 chr19:23891668-23891679
40	CEBPB	chr19:23954195-23954412	HepG2	liver:	n/a	n/a
41	CEBPB	chr19:23959151-23959571	HepG2	liver:	n/a	n/a
42	CEBPB	chr19:23962499-23962745	IMR90	lung:	n/a	n/a
43	CEBPB	chr19:23934755-23935037	MCF-7	breast:	n/a	n/a
44	CEBPB	chr19:23883184-23883426	K562	blood:	n/a	n/a
45	CEBPB	chr19:23959786-23960810	HepG2	liver:	n/a	n/a
46	CEBPB	chr19:23967860-23968049	HepG2	liver:	n/a	n/a
47	CEBPB	chr19:23964778-23965190	IMR90	lung:	n/a	n/a
48	CEBPB	chr19:23968010-23968382	K562	blood:	n/a	n/a
49	CEBPB	chr19:23966073-23966823	HepG2	liver:	n/a	chr19:23966205-23966216 chr19:23966237-23966248
50	CEBPB	chr19:23964650-23965334	A549	lung:	n/a	n/a

(count:1464 , 50 per page) page: 1 2 3 4 5 6 7 ... 30

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr19:23945659-23945709	GM19239	blood:	n/a
2	chr19:23941871-23941921	HCM	heart:	n/a
3	chr19:23945659-23945709	HMEC	breast:	n/a
4	chr19:23942126-23942176	HNPCEpiC	eye:	n/a
5	chr19:23945472-23945522	H1-hESC	embryonic stem cell:	embryo
6	chr19:23941575-23941625	A549	lung:	n/a
7	chr19:23946205-23946255	NT2-D1	testis:	n/a
8	chr19:23941207-23941257	SK-N-SH_RA	brain:	n/a
9	chr19:23942040-23942090	Caco-2	colon:	n/a
10	chr19:23945659-23945709	HAEpiC	amniotic membrane:	n/a
11	chr19:23945722-23945772	U87	brain:	n/a
12	chr19:23941767-23941817	HepG2	liver:	n/a
13	chr19:23945996-23946046	AG09319	gingival:	n/a
14	chr19:23945722-23945772	MCF10A-Er-Src	breast:	n/a
15	chr19:23945659-23945709	NHBE	bronchial:	n/a
16	chr19:23941871-23941921	H1-hESC	embryonic stem cell:	embryo
17	chr19:23945472-23945522	HCT-116	colon:	n/a
18	chr19:23941313-23941363	HRCEpiC	kidney:	n/a
19	chr19:23941718-23941768	PrEC	prostate:	n/a
20	chr19:23945472-23945522	NH-A	brain:	n/a
21	chr19:23942073-23942123	HL-60	blood:	n/a
22	chr19:23944615-23944665	LNCaP	prostate:	n/a
23	chr19:23945743-23945793	Hela-S3	cervix:	n/a
24	chr19:23945203-23945253	ECC-1	luminal epithelium:	n/a
25	chr19:23941408-23941458	ovcar-3	ovarian:	n/a
26	chr19:23945659-23945709	LNCaP	prostate:	n/a
27	chr19:23941313-23941363	U87	brain:	n/a
28	chr19:23942126-23942176	NT2-D1	testis:	n/a
29	chr19:23945996-23946046	HepG2	liver:	n/a
30	chr19:23941575-23941625	SKMC	muscle:	n/a
31	chr19:23945996-23946046	AG09309	skin:	n/a
32	chr19:23942040-23942090	SK-N-SH_RA	brain:	n/a
33	chr19:23941207-23941257	AG09309	skin:	n/a
34	chr19:23945472-23945522	GM06990	blood:	n/a
35	chr19:23941711-23941761	Jurkat	blood:	n/a
36	chr19:23941207-23941257	NB4	blood:	n/a
37	chr19:23941207-23941257	HRCEpiC	kidney:	n/a
38	chr19:23945203-23945253	AG04450	lung:	fetal
39	chr19:23942040-23942090	H1-hESC	embryonic stem cell:	embryo
40	chr19:23945761-23945811	HEEpiC	esophagus:	n/a
41	chr19:23945472-23945522	HPAEpiC	pulmonary alveolar:	n/a
42	chr19:23946205-23946255	HIPEpiC	eye:	n/a
43	chr19:23946205-23946255	PANC-1	pancreas:	n/a
44	chr19:23941871-23941921	AoSMC	blood vessel:	n/a
45	chr19:23942126-23942176	Jurkat	blood:	n/a
46	chr19:23942040-23942090	T-47D	breast:	n/a
47	chr19:23945659-23945709	NT2-D1	testis:	n/a
48	chr19:23941313-23941363	HEEpiC	esophagus:	n/a
49	chr19:23945761-23945811	CMK	blood:	n/a
50	chr19:23945996-23946046	AG04450	lung:	fetal

(count:16 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr19:23947709..23949776-chr19:23958415..23961237,2	K562	blood:
2	chr19:23934332..23937161-chr19:23938726..23941711,2	K562	blood:
3	chr19:23900187..23902278-chr19:23940194..23942513,2	K562	blood:
4	chr19:23939020..23940771-chr19:23944929..23946876,2	K562	blood:
5	chr19:23935159..23938010-chr19:23940371..23942575,2	K562	blood:
6	chr19:23956310..23957870-chr19:23960230..23962213,2	K562	blood:
7	chr19:23944623..23946640-chr19:23952768..23956450,3	MCF-7	breast:
8	chr16:10416054..10418828-chr19:23906524..23908025,2	MCF-7	breast:
9	chr19:23940633..23942866-chr19:23945047..23947463,3	K562	blood:
10	chr19:23947709..23949776-chr19:23958415..23961237,2	K562	blood:
11	chr19:23940633..23942866-chr19:23945047..23947463,3	K562	blood:
12	chr19:23956310..23957870-chr19:23960230..23962213,2	K562	blood:
13	chr19:23941209..23941866-chr7:64126456..64127217,2	Hela-S3	cervix:
14	chr19:23868466..23870977-chr19:23872417..23875896,3	MCF-7	breast:
15	chr19:23946413..23950001-chr19:23953368..23955533,3	K562	blood:
16	chr19:23946413..23950001-chr19:23953368..23955533,3	K562	blood:

(count:8 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-RPSAP58-2	chr19:23945814-23945936	NONHSAT063934
2	lnc-RPSAP58-2	chr19:23945746-23945936	NONHSAT063933
3	lnc-ZNF726-1	chr19:23968384-23969193	ENSG00000250795
4	lnc-ZNF675-3	chr19:23924178-23924868	l_1665_chr19:23924177-23932637_testes
5	lnc-ZNF675-2	chr19:23922003-23923732	NONHSAT063932
6	lnc-RPSAP58-2	chr19:23964883-23965301	NONHSAT063935
7	lnc-ZNF675-3	chr19:23932373-23932637	l_1665_chr19:23924177-23932637_testes
8	lnc-ZNF675-3	chr19:23926812-23927078	l_1665_chr19:23924177-23932637_testes

No data

Variant related genes	Relation type
RPSAP58	TF binding region
ZNF681	TF binding region
ZNF675	TF binding region
ENSG00000233836	TF binding region
RPSAP58	CpG island
ZNF681	CpG island
ZNF675	CpG island
ENSG00000233836	CpG island
ENSG00000196172	chromatin interactions
ENSG00000205246	chromatin interactions
ENSG00000197372	chromatin interactions
ENSG00000196247	chromatin interactions
ENSG00000233836	chromatin interactions
TIAL1	miRNA target sites

Extended variants
information (count: 2971 )
Associated
traits (count: 40 )

Variant overlapped rSNPs/rCNVs (count:2971 , 50 per page) page: 1 2 3 4 5 6 7 ... 60

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs557527458	chr19:23871466-23871467	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs369868668	chr19:23871476-23871477	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs576090786	chr19:23871498-23871499	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs546112297	chr19:23871519-23871520	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs558121218	chr19:23871550-23871551	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs146770939	chr19:23871605-23871606	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs111400891	chr19:23871608-23871609	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs528932774	chr19:23871640-23871641	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs75606754	chr19:23871651-23871652	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs547749001	chr19:23871663-23871664	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs199691748	chr19:23871664-23871665	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs60096163	chr19:23871665-23871666	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs118114590	chr19:23871741-23871742	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs4932903	chr19:23871927-23871928	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
15	rs551963189	chr19:23871933-23871934	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs4932904	chr19:23871939-23871940	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
17	rs4932905	chr19:23871948-23871949	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
18	rs112111228	chr19:23871958-23871959	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs7257743	chr19:23871985-23871986	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
20	rs141198563	chr19:23871998-23871999	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs114789246	chr19:23872042-23872043	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs181458226	chr19:23872056-23872057	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs539211506	chr19:23872060-23872061	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs578118631	chr19:23872068-23872069	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs576022480	chr19:23872086-23872087	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs145020692	chr19:23872195-23872196	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs555530441	chr19:23872199-23872200	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs186402439	chr19:23872210-23872211	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs541069820	chr19:23872242-23872243	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs561841933	chr19:23872285-23872286	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs75348027	chr19:23872330-23872331	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs575263616	chr19:23872468-23872469	Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs559757741	chr19:23872470-23872471	Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs143737263	chr19:23872508-23872509	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
35	rs369518268	chr19:23872734-23872735	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
36	rs192007222	chr19:23872762-23872763	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
37	rs540393146	chr19:23872857-23872858	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
38	rs550151705	chr19:23872875-23872876	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
39	rs10402075	chr19:23872884-23872885	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
40	rs148141864	chr19:23872910-23872911	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
41	rs549060976	chr19:23872914-23872915	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
42	rs567459938	chr19:23873013-23873014	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
43	rs182268234	chr19:23873033-23873034	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
44	rs546592461	chr19:23873050-23873051	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
45	rs185956079	chr19:23873066-23873067	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
46	rs544184669	chr19:23873160-23873161	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
47	rs539736860	chr19:23873180-23873181	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
48	rs551422900	chr19:23873184-23873185	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
49	rs144033335	chr19:23873190-23873191	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
50	rs564104750	chr19:23873192-23873193	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:40)

Disease	PMID	Source
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Prostate cancer	16573809	CNVD
Chordoma	18071362	CNVD
Metanephric adenoma	20802469	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	21979893	CNVD
Oligodendroglial tumors	17285580	CNVD
Oral cancer	21386901	CNVD
ovarian endometriomas	16273235	CNVD
Endometrial cancer	22040021	CNVD
Acute myeloid leukemia	16864856	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	17387387	CNVD
Cervical cancer	21063398	CNVD
Myelodysplastic syndrome	17634407	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Retinoblastoma	21504564	CNVD
Ovarian cancer	21720365	CNVD
Cancer	20164919	CNVD
Thoracic aortic aneurysm	21092924	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Prostate cancer	18632612	CNVD
Autism	22495311	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Acute lymphoblastic leukemia	21248843	CNVD
Lung cancer	18438408	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Myelofibrosis	22110671	CNVD
Cancer	21183584	CNVD
Colorectal cancer	20459617	CNVD
Ductal carcinoma	22052326	CNVD
Cancer	20164920	CNVD
small cell lung cancer	20016488	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:1674 , 50 per page) page: 1 2 3 4 5 6 7 ... 34

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr19:23870000-23872200	Weak transcription	Sigmoid Colon	Sigmoid Colon
2	chr19:23870200-23871600	Enhancers	Primary T helper cells PMA-I stimulated	--
3	chr19:23870200-23871800	Enhancers	Primary T helper naive cells fromperipheralblood	blood
4	chr19:23870200-23872000	Weak transcription	Primary B cells from cord blood	blood
5	chr19:23870200-23875200	Weak transcription	Placenta	Placenta
6	chr19:23870600-23872000	Enhancers	Primary T helper cells fromperipheralblood	blood
7	chr19:23870600-23881200	Weak transcription	iPS-15b Cell Line	embryonic stem cell
8	chr19:23871400-23872600	Weak transcription	Primary T killer naive cells fromperipheralblood	blood
9	chr19:23872800-23873000	Enhancers	Primary T killer naive cells fromperipheralblood	blood
10	chr19:23875200-23876000	Enhancers	Placenta	Placenta
11	chr19:23876000-23881400	Weak transcription	Placenta	Placenta
12	chr19:23876400-23877000	Enhancers	HUES6 Cell Line	embryonic stem cell
13	chr19:23877200-23877400	Enhancers	Primary T helper naive cells from peripheral blood	blood
14	chr19:23880200-23880600	ZNF genes & repeats	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
15	chr19:23880600-23882800	Enhancers	HUES48 Cell Line	embryonic stem cell
16	chr19:23881200-23881400	Enhancers	Rectal Mucosa Donor 29	rectum
17	chr19:23881200-23881400	Enhancers	NHEK	skin
18	chr19:23881200-23882600	Enhancers	iPS-15b Cell Line	embryonic stem cell
19	chr19:23881400-23881600	Enhancers	ES-WA7 Cell Line	embryonic stem cell
20	chr19:23881400-23881600	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
21	chr19:23881400-23881800	Enhancers	ES-I3 Cell Line	embryonic stem cell
22	chr19:23881400-23881800	Enhancers	HUES6 Cell Line	embryonic stem cell
23	chr19:23881400-23881800	Enhancers	Breast Myoepithelial Primary Cells	Breast
24	chr19:23881400-23881800	Flanking Active TSS	Rectal Mucosa Donor 29	rectum
25	chr19:23881400-23882200	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
26	chr19:23881400-23882600	Enhancers	iPS-20b Cell Line	embryonic stem cell
27	chr19:23881400-23882800	Enhancers	HUES64 Cell Line	embryonic stem cell
28	chr19:23881400-23882800	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
29	chr19:23881400-23883000	Flanking Active TSS	NHEK	skin
30	chr19:23881400-23883400	Enhancers	Placenta	Placenta
31	chr19:23881600-23881800	Enhancers	K562	blood
32	chr19:23881600-23882200	Active TSS	Rectal Mucosa Donor 31	rectum
33	chr19:23881600-23882400	Enhancers	H9 Cell Line	embryonic stem cell
34	chr19:23881600-23882400	Enhancers	Esophagus	oesophagus
35	chr19:23881600-23882800	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
36	chr19:23881800-23882000	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
37	chr19:23881800-23882000	Active TSS	Rectal Mucosa Donor 29	rectum
38	chr19:23881800-23882200	Flanking Active TSS	Breast Myoepithelial Primary Cells	Breast
39	chr19:23881800-23882200	Active TSS	K562	blood
40	chr19:23881800-23882400	Flanking Active TSS	ES-I3 Cell Line	embryonic stem cell
41	chr19:23881800-23882400	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
42	chr19:23881800-23882400	Active TSS	HepG2	liver
43	chr19:23881800-23882600	Flanking Active TSS	HUES6 Cell Line	embryonic stem cell
44	chr19:23881800-23882600	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
45	chr19:23881800-23882600	Enhancers	Colon Smooth Muscle	Colon
46	chr19:23882000-23882200	Flanking Active TSS	Rectal Mucosa Donor 29	rectum
47	chr19:23882200-23882400	Active TSS	Rectal Mucosa Donor 29	rectum
48	chr19:23882200-23882400	Flanking Active TSS	Rectal Mucosa Donor 31	rectum
49	chr19:23882200-23882400	Flanking Active TSS	K562	blood
50	chr19:23882200-23882600	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links